Novo Nordisk’s Post

In an ecosystem modulated by a working balance between patients, emerging science, and funding capital, patients and advancing technology are seemingly taking center stage in driving innovation in clinical trials. https://lnkd.in/gxrca2zE

In an ecosystem modulated by a working balance between patients, emerging science, and funding capital, patients and advancing technology are seemingly taking center stage in driving innovation in clinical trials. https://lnkd.in/ebtimSi5

In an ecosystem modulated by a working balance between patients, emerging science, and funding capital, patients and advancing technology are seemingly taking center stage in driving innovation in clinical trials. https://lnkd.in/gcYF2KBb

In an ecosystem modulated by a working balance between patients, emerging science, and funding capital, patients and advancing technology are seemingly taking center stage in driving innovation in clinical trials. https://lnkd.in/g6sBa4Xb

In an ecosystem modulated by a working balance between patients, emerging science, and funding capital, patients and advancing technology are seemingly taking center stage in driving innovation in clinical trials. https://lnkd.in/gJWWDCZ5

In an ecosystem modulated by a working balance between patients, emerging science, and funding capital, patients and advancing technology are seemingly taking center stage in driving innovation in clinical trials. https://lnkd.in/gVmirGRq

In an ecosystem modulated by a working balance between patients, emerging science, and funding capital, patients and advancing technology are seemingly taking center stage in driving innovation in clinical trials. https://lnkd.in/eJErjtPk

We created our Innovation Ecosystem to break down barriers that hinder ALS research and drug discovery. Designed around six principles, the Innovation Ecosystem aims to attract the best ideas from global scientists and provide comprehensive support to guide those ideas from the laboratory to the clinic. The six principles are: 🤝 Collaborative Funding 🔬 Scientific Tools and Resources 🔍 Independent Grant Review 🔓 No IP Restrictions 💼 Industry Engagement 👥 Networking & Communications Paramount to the success of our model is our emphasis on collaboration, which brings scientists and industry partners from around the globe together to accelerate the drug discovery process. By leveraging each stakeholder's expertise and sharing all data and research, these collaborations more rapidly move the needle on biomarker discovery and treatment development for ALS. Learn more about the Innovation Ecosystem: https://bit.ly/3Seni62 #ALS #ALSresearch #Strategy #Collaboration #Innovation #MedicalResearch #Research

We have recently launched the Life Sciences Index, a study about perceptions of innovation and growth in the sector. We surveyed 200 industry leaders for their insights on topics including dealmaking, ESG, intelligent technology and the future of care delivery. The report had some interesting feedback including nearly half of respondents predicting an uptick in M&A activity in the sector in the next 12 months but only 36% of respondents seeing AI as a strategic priority and just 13% seeing ESG as a priority. Access the report here: Life Sciences Index 2024: A study of innovation and growth for the world’s largest biopharma and medtech companies | DLA Piper

"Join us at the HTAi 2024 Annual Meeting to explore how collaborative networks can address the emerging challenges in healthcare technology assessment. Together, we can drive innovation and sustainable development!" - Hameed Khan, HTAi Executive Director